EUROFINS SCIENT Total Long-Term Assets 2018-2024 | ERFSF

EUROFINS SCIENT total long-term assets from 2018 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • EUROFINS SCIENT total long-term assets for the quarter ending December 31, 2024 were $12.240B, a 12.4% increase year-over-year.
  • EUROFINS SCIENT total long-term assets for 2024 were $9.129B, a 7.83% increase from 2023.
  • EUROFINS SCIENT total long-term assets for 2023 were $8.466B, a 3.41% increase from 2022.
  • EUROFINS SCIENT total long-term assets for 2022 were $8.187B, a 1.33% decline from 2021.
EUROFINS SCIENT Annual Total Long-Term Assets
(Millions of US $)
2024 $9,129
2023 $8,466
2022 $8,187
2021 $8,297
2020 $6,919
2019 $6,965
2018 $6,496
2017 $4,528
2016 $0
2015 $0
EUROFINS SCIENT Quarterly Total Long-Term Assets
(Millions of US $)
2024-12-31 $12,240
2024-06-30 $8,813
2023-06-30 $6,025
2022-12-31 $10,893
2021-12-31 $10,890
2021-06-30 $5,519
2020-12-31 $8,941
2020-06-30 $5,048
2019-12-31 $8,733
2019-06-30 $5,205
2018-12-31 $7,834
2018-06-30 $4,185
2017-12-31 $5,630
Sector Industry Market Cap Revenue
Medical Medical Services $13.026B $7.522B
Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $145.009B 27.20
Elevance Health (ELV) United States $86.741B 11.19
CVS Health (CVS) United States $81.290B 10.10
Cencora (COR) United States $55.092B 19.17
DiDi Global (DIDIY) China $23.485B 35.64
Natera (NTRA) United States $22.560B 0.00
BioMerieux (BMXMF) France $16.856B 0.00
Solventum (SOLV) United States $13.071B 13.84
ICON (ICLR) Ireland $11.688B 10.87
Revvity (RVTY) United States $11.345B 19.52
CochLear (CHEOY) Australia $11.134B 0.00
Doximity (DOCS) United States $10.995B 50.90
Viatris (VTRS) United States $10.610B 3.65
Avantor (AVTR) United States $9.329B 13.55
HealthEquity (HQY) United States $9.272B 40.61
Medpace Holdings (MEDP) United States $8.792B 23.35
Sonic Healthcare (SKHHY) Australia $8.450B 0.00
Charles River Laboratories (CRL) United States $7.416B 14.53
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.450B 26.21
BrightSpring Health Services (BTSG) United States $3.875B 35.87
Sotera Health (SHC) United States $3.491B 19.84
Surgery Partners (SGRY) United States $2.989B 38.87
Alignment Healthcare (ALHC) United States $2.898B 0.00
Concentras Parent (CON) United States $2.816B 16.27
Organon (OGN) United States $2.610B 2.77
GeneDx Holdings (WGS) United States $1.983B 76.39
Progyny (PGNY) United States $1.923B 42.32
Ardent Health Partners (ARDT) United States $1.920B 8.18
Premier (PINC) United States $1.884B 14.30
PACS (PACS) United States $1.629B 0.00
GoodRx Holdings (GDRX) United States $1.622B 32.43
Teladoc Health (TDOC) United States $1.298B 0.00
Pediatrix Medical (MD) United States $1.213B 9.23
Establishment Labs Holdings (ESTA) $1.124B 0.00
CareDx (CDNA) United States $1.105B 17.26
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.944B 0.00
AMN Healthcare Services Inc (AMN) United States $0.843B 7.89
QDM (QDMI) Hong Kong, SAR China $0.752B 0.00
Nutex Health (NUTX) United States $0.651B 9.85
Embecta (EMBC) United States $0.592B 3.99
LifeMD (LFMD) United States $0.553B 0.00
Enhabit (EHAB) United States $0.543B 44.67
InnovAge Holding (INNV) United States $0.514B 0.00
SBC Medicals (SBC) United States $0.495B 0.00
Sonida Senior Living (SNDA) United States $0.474B 0.00
Auna S.A (AUNA) Luxembourg $0.470B 10.58
COMPASS Pathways (CMPS) United Kingdom $0.445B 0.00
Performant Healthcare (PHLT) United States $0.258B 0.00
Oncology Institute (TOI) United States $0.237B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
DocGo (DCGO) United States $0.156B 25.50
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.104B 0.00
So-Young (SY) China $0.090B 0.00
OncoCyte (OCX) United States $0.079B 0.00
Basel Medical Group (BMGL) Singapore $0.075B 0.00
KindlyMD (NAKA) United States $0.070B 0.00
Ascend Wellness Holdings (AAWH) United States $0.060B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Sera Prognostics (SERA) United States $0.056B 0.00
Biodesix (BDSX) United States $0.048B 0.00
ModivCare (MODV) United States $0.047B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00